Clinical Trial Update: Gemcitabine and Ifosfamide As a Second-Line Systemic Chemotherapy for Cisplatin -Failed Advanced TCC [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating gemcitabine combined with ifosfamide as second-line chemotherapy for cisplatin-failed advanced transitional cell carcinoma has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Transitional Cell Carcinoma

Drugs mentioned

• Gemcitabine (Gemzar) (gemcitabine)
• IFOSFAMIDE (IFOSFAMIDE)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Transitional Cell Carcinoma | Phase 2 | Status: COMPLETED